Predoctoral Training Program in Molecular Pharmacology and Experimental Therapeutics Student Roster

Ph.D. trainee prepares cells for an experiment to test a new drug.


Review the focus areas, mentors and publications of current and former trainees in the Predoctoral Training Program in Molecular Pharmacology and Experimental Therapeutics at Mayo Clinic.

Appointee Mentor Research focus Mayo Clinic publications
Carly A. Baehr Larry M. Karnitz, Ph.D. Regulation of base excision repair by glycogen synthase kinase 3 (GSK-3)-mediated phosphorylation of uracil N-glycosylase 2 (UNG2) View publications
Adebowale (Wale) O. Bamidele, Ph.D. Karen E. Hedin, Ph.D. IQGAP1 and other proteins that mediate cytoskeletal interactions: Critical roles in regulating CXCR4 trafficking, signaling and disease View publications
Sherri M. Biendarra-Tiegs Timothy J. Nelson, M.D., Ph.D. Evaluation and modulation of cardiomyocyte subtype development from human View publications
Steven M. Dotzler Michael J. Ackerman, M.D., Ph.D. Suppression-replacement KCNQ1 gene therapy for type 1 long QT syndrome View publications
Jordan M. Grainger Liewei Wang, M.D., Ph.D. Study of genomic aberrations and drug response in breast cancer and metastatic castration-resistant prostate cancer View publications
Carl T. Gustafson Michael J. Yaszemski, M.D., Ph.D. Wnt targets and therapeutic approaches in osteosarcoma View publications
Katherine A Hartjes Timothy J. Nelson, M.D., Ph.D. Mapping cell-autonomous cardiogenic signatures of bioengineered cardiac progenitors according to native cardiogenesis View publications
Erin M. Higgins Michael J. Ackerman, M.D., Ph.D. Elucidation of MRAS-mediated Noonan syndrome with cardiac hypertrophy View publications
Jamie D. Kapplinger, M.D., Ph.D. Michael J. Ackerman, M.D., Ph.D. Enhanced classification of nonsynonymous single nucleotide variants in the sodium voltage-gated channel alpha subunit 5 (SCN5A)-encoded NaV1.5 cardiac sodium channel View publications
Rebecca L. Kelly Larry M. Karnitz, Ph.D. The intra-synthesis (intra-S) phase checkpoint regulates Treslin to suppress new origin firing View publications
Christopher Livia Atta Behfar, M.D., Ph.D. Regenerative interventions in cardiac ischemia View publications
Pamela A. Long Timothy W. Olsen, M.D. Discovering molecular genetic defects underlying pediatric dilated cardiomyopathy View publications
Cordelia D. McGehee Scott H. Kaufmann, M.D., Ph.D. Acquired poly ADP ribose polymerase (PARP) inhibitor resistance in preclinical models of high-grade serous ovarian cancer View publications
Katherine Minter Dykhouse Timothy J. Nelson, M.D., Ph.D. Modeling terminal differentiation of cardiomyocytes using the directed differentiation of human induced pluripotent stem cells to cardiomyocytes View publications
Drew R. Neavin, Ph.D. Richard Weinshilboum, M.D. Metabolomics and single nucleotide polymorphism analyses to identify genetic components of response to SSRIs View publications
Alfred D. Nelson Diana Gil Pages, Ph.D. Anti-TCR (T cell receptors) and anti-CD3 Fab homodimerization and the effects of ligand bivalency on T cell activation View publications
Lee R. Peyton, Ph.D. Doo-Sup Choi, Ph.D. Neuropharmacology of alcohol use disorder and psychiatric disorder View publications
Stephanie L. Safgren, Ph.D. Martin E. Fernandez-Zapico, M.D. The chromatin remodeler SMARCA2 cooperates with GLI1 to regulate gene expression in pancreatic cancer cells View publications
Tamiel N. Turley, Ph.D. Timothy W. Olsen, M.D. Identifying the genetic underpinnings of spontaneous coronary artery dissection View publications
Taylor M. Weiskittel Hu Li, Ph.D. Systems biology-enabled precision medicine View publications
Elizabeth K. Wiese Taro Hitosugi, Ph.D. Keto acids and cancer metabolism View publications

Review career outcomes for alumni of the T32 Predoctoral Training Program in Molecular Pharmacology and Experimental Therapeutics (MPET) at Mayo Clinic:

Current career Former MPET T32 Ph.D. and M.D.-Ph.D. trainees*
Research — academic faculty 42%
Research — academic staff 17%
Research — industry 17%
Research — government 8%
Teaching — faculty 8%
Medical practice 0%
Other industry or medical career 8%
*Trainees supported by the National Institute of General Medical Sciences-funded Predoctoral Training Program in Molecular Pharmacology and Experimental Therapeutics (MPET) for the last 15 years.